Bank of New York Mellon’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $102K | Sell |
|
|||||
|
2022
Q3 | $806K | Sell |
|
|||||
|
2022
Q2 | $598K | Buy |
|
|||||
|
2022
Q1 | $60K | Buy |
|
|||||
|
2021
Q4 | $56K | Hold |
|
|||||
|
2021
Q3 | $58K | Hold |
|
|||||
|
2021
Q2 | $74K | Sell |
|
|||||
|
2021
Q1 | $535K | Buy |
|
|||||
|
2020
Q4 | $1.26M | Sell |
|
|||||
|
2020
Q3 | $1M | Sell |
|
|||||
|
2020
Q2 | $1.02M | Buy |
|
|||||
|
2020
Q1 | $892K | Buy |
|
|||||
|
2019
Q4 | $779K | Buy |
|
|||||
|
2019
Q3 | $491K | Sell |
|
|||||
|
2019
Q2 | $1.1M | Sell |
|
|||||
|
2019
Q1 | $1.28M | Buy |
|
|||||
|
2018
Q4 | $1.31M | Sell |
|
|||||
|
2018
Q3 | $2.68M | Buy |
|
|||||
|
2018
Q2 | $2.88M | Buy |
|
|||||
|
2018
Q1 | $3.61M | Sell |
|
|||||
|
2017
Q4 | $5.13M | Buy |
|
|||||
|
2017
Q3 | $1.88M | Buy |
|
|||||
|
2017
Q2 | $1.76M | Buy |
|
|||||
|
2017
Q1 | $2.12M | Buy |
|
|||||
|
2016
Q4 | $1.23M | Buy |
|
|||||
|
2016
Q3 | $1.13M | Sell |
|
|||||
|
2016
Q2 | $1.41M | Buy |
|
|||||
|
2016
Q1 | $1.68M | Sell |
|
|||||
|
2015
Q4 | $2.41M | Sell |
|
|||||
|
2015
Q3 | $4.4M | Sell |
|
|||||
|
2015
Q2 | $3.77M | Buy |
|
|||||
|
2015
Q1 | $2M | Sell |
|
|||||
|
2014
Q4 | $1.79M | Sell |
|
|||||
|
2014
Q3 | $2.18M | Buy |
|
|||||
|
2014
Q2 | $723K | Buy |
|
|||||
|
2014
Q1 | $218K | Buy |
|